PG
Therapeutic Areas
Neuromagen Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AGS‑499 | Amyotrophic Lateral Sclerosis (ALS) | Preclinical |
Leadership Team at Neuromagen Pharma
PE
Prof. Esther Priel, DSc
Founder, CEO & CSO
DD
Daniella Dayan, B.Sc., MBA
Chief Operating Officer
DH
Dr. Helena Grinberg‑Rashi, Ph.D., MBA
Senior Clinical and Regulatory Advisor
DE
Dr. Elad Bar Gil, MD
Chief Medical Officer
DH
Dr. Hananel Elul, Ph.D.
Researcher
DT
Dr. Tatyana Glukovsky, Ph.D.
Researcher
PD
Prof. David Stepensky, Ph.D.
Scientific Advisory Board
MI
Mr. Iftach Seri, M.Sc., MBA
CEO, CTS Ltd.